7,196 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by AssuredPartners Investment Advisors LLC

AssuredPartners Investment Advisors LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 7,196 shares of the healthcare conglomerate's stock, valued at approximately $3,640,000.

A number of other institutional investors also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Promus Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $40,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.0 %

UNH traded down $0.25 on Friday, reaching $515.47. 2,378,211 shares of the company traded hands, compared to its average volume of 4,268,981. The company has a market cap of $471.51 billion, a P/E ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The firm has a fifty day simple moving average of $508.81 and a two-hundred day simple moving average of $544.24. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research analyst reports. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research note on Tuesday, December 3rd. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Buy" and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.